Royal Bank of Canada’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.71M | Buy |
333,752
+331,996
| +18,906% | +$7.67M | ﹤0.01% | 2022 |
|
|
2025
Q1 | $47K | Sell |
1,756
-14,632
| -89% | -$392K | ﹤0.01% | 5219 |
|
|
2024
Q4 | $878K | Buy |
16,388
+7,369
| +82% | +$395K | ﹤0.01% | 3247 |
|
|
2024
Q3 | $410K | Sell |
9,019
-15,500
| -63% | -$705K | ﹤0.01% | 3836 |
|
|
2024
Q2 | $1.03M | Buy |
24,519
+22,932
| +1,445% | +$961K | ﹤0.01% | 3101 |
|
|
2024
Q1 | $60K | Sell |
1,587
-3,110
| -66% | -$118K | ﹤0.01% | 5016 |
|
|
2023
Q4 | $51K | Buy |
4,697
+1,300
| +38% | +$14.1K | ﹤0.01% | 5451 |
|
|
2023
Q3 | $34K | Buy |
3,397
+1,614
| +91% | +$16.2K | ﹤0.01% | 5488 |
|
|
2023
Q2 | $21K | Buy |
1,783
+823
| +86% | +$9.69K | ﹤0.01% | 5732 |
|
|
2023
Q1 | $12K | Sell |
960
-1,221
| -56% | -$15.3K | ﹤0.01% | 5845 |
|
|
2022
Q4 | $28K | Buy |
2,181
+1,947
| +832% | +$25K | ﹤0.01% | 5690 |
|
|
2022
Q3 | $3K | Buy |
234
+137
| +141% | +$1.76K | ﹤0.01% | 6405 |
|
|
2022
Q2 | $1K | Sell |
97
-995
| -91% | -$10.3K | ﹤0.01% | 6672 |
|
|
2022
Q1 | $16K | Sell |
1,092
-1,860
| -63% | -$27.3K | ﹤0.01% | 6232 |
|
|
2021
Q4 | $58K | Buy |
2,952
+115
| +4% | +$2.26K | ﹤0.01% | 5760 |
|
|
2021
Q3 | $61K | Buy |
2,837
+1,537
| +118% | +$33K | ﹤0.01% | 5526 |
|
|
2021
Q2 | $32K | Buy |
+1,300
| New | +$32K | ﹤0.01% | 5805 |
|